ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization ConferenceGlobeNewsWire • 10/19/21
ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.GlobeNewsWire • 10/18/21
ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021GlobeNewsWire • 10/04/21
ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021GlobeNewsWire • 10/01/21
ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare ConferenceGlobeNewsWire • 09/02/21
ADMA Biologics: Recent Significant Developments And Their Implications For The StockSeeking Alpha • 08/22/21
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TNGlobeNewsWire • 08/16/21
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/12/21
ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and AccomplishmentsGlobeNewsWire • 08/11/21
ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics' Persona Technology for NexSys Plasma Collection SystemGlobeNewsWire • 08/10/21
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB®GlobeNewsWire • 08/09/21
ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021GlobeNewsWire • 08/04/21
Will Adma Biologics (ADMA) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/28/21
ADMA Biologics Inc. (ADMA) CEO Adam Grossman on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/13/21
ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and AccomplishmentsGlobeNewsWire • 05/12/21